Cargando…
TransSynW: A single‐cell RNA‐sequencing based web application to guide cell conversion experiments
Generation of desired cell types by cell conversion remains a challenge. In particular, derivation of novel cell subtypes identified by single‐cell technologies will open up new strategies for cell therapies. The recent increase in the generation of single‐cell RNA‐sequencing (scRNA‐seq) data and th...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848352/ https://www.ncbi.nlm.nih.gov/pubmed/33125830 http://dx.doi.org/10.1002/sctm.20-0227 |
_version_ | 1783645116794142720 |
---|---|
author | Ribeiro, Mariana Messias Okawa, Satoshi del Sol, Antonio |
author_facet | Ribeiro, Mariana Messias Okawa, Satoshi del Sol, Antonio |
author_sort | Ribeiro, Mariana Messias |
collection | PubMed |
description | Generation of desired cell types by cell conversion remains a challenge. In particular, derivation of novel cell subtypes identified by single‐cell technologies will open up new strategies for cell therapies. The recent increase in the generation of single‐cell RNA‐sequencing (scRNA‐seq) data and the concomitant increase in the interest expressed by researchers in generating a wide range of functional cells prompted us to develop a computational tool for tackling this challenge. Here we introduce a web application, TransSynW, which uses scRNA‐seq data for predicting cell conversion transcription factors (TFs) for user‐specified cell populations. TransSynW prioritizes pioneer factors among predicted conversion TFs to facilitate chromatin opening often required for cell conversion. In addition, it predicts marker genes for assessing the performance of cell conversion experiments. Furthermore, TransSynW does not require users' knowledge of computer programming and computational resources. We applied TransSynW to different levels of cell conversion specificity, which recapitulated known conversion TFs at each level. We foresee that TransSynW will be a valuable tool for guiding experimentalists to design novel protocols for cell conversion in stem cell research and regenerative medicine. |
format | Online Article Text |
id | pubmed-7848352 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78483522021-02-05 TransSynW: A single‐cell RNA‐sequencing based web application to guide cell conversion experiments Ribeiro, Mariana Messias Okawa, Satoshi del Sol, Antonio Stem Cells Transl Med Enabling Technologies for Cell‐based Clinical Translation Generation of desired cell types by cell conversion remains a challenge. In particular, derivation of novel cell subtypes identified by single‐cell technologies will open up new strategies for cell therapies. The recent increase in the generation of single‐cell RNA‐sequencing (scRNA‐seq) data and the concomitant increase in the interest expressed by researchers in generating a wide range of functional cells prompted us to develop a computational tool for tackling this challenge. Here we introduce a web application, TransSynW, which uses scRNA‐seq data for predicting cell conversion transcription factors (TFs) for user‐specified cell populations. TransSynW prioritizes pioneer factors among predicted conversion TFs to facilitate chromatin opening often required for cell conversion. In addition, it predicts marker genes for assessing the performance of cell conversion experiments. Furthermore, TransSynW does not require users' knowledge of computer programming and computational resources. We applied TransSynW to different levels of cell conversion specificity, which recapitulated known conversion TFs at each level. We foresee that TransSynW will be a valuable tool for guiding experimentalists to design novel protocols for cell conversion in stem cell research and regenerative medicine. John Wiley & Sons, Inc. 2020-10-08 /pmc/articles/PMC7848352/ /pubmed/33125830 http://dx.doi.org/10.1002/sctm.20-0227 Text en © 2020 The Authors. stem cells translational medicine published by Wiley Periodicals LLC on behalf of AlphaMed Press. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Enabling Technologies for Cell‐based Clinical Translation Ribeiro, Mariana Messias Okawa, Satoshi del Sol, Antonio TransSynW: A single‐cell RNA‐sequencing based web application to guide cell conversion experiments |
title |
TransSynW: A single‐cell RNA‐sequencing based web application to guide cell conversion experiments |
title_full |
TransSynW: A single‐cell RNA‐sequencing based web application to guide cell conversion experiments |
title_fullStr |
TransSynW: A single‐cell RNA‐sequencing based web application to guide cell conversion experiments |
title_full_unstemmed |
TransSynW: A single‐cell RNA‐sequencing based web application to guide cell conversion experiments |
title_short |
TransSynW: A single‐cell RNA‐sequencing based web application to guide cell conversion experiments |
title_sort | transsynw: a single‐cell rna‐sequencing based web application to guide cell conversion experiments |
topic | Enabling Technologies for Cell‐based Clinical Translation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848352/ https://www.ncbi.nlm.nih.gov/pubmed/33125830 http://dx.doi.org/10.1002/sctm.20-0227 |
work_keys_str_mv | AT ribeiromarianamessias transsynwasinglecellrnasequencingbasedwebapplicationtoguidecellconversionexperiments AT okawasatoshi transsynwasinglecellrnasequencingbasedwebapplicationtoguidecellconversionexperiments AT delsolantonio transsynwasinglecellrnasequencingbasedwebapplicationtoguidecellconversionexperiments |